Nykredit A S acquired a new stake in Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) in the 2nd quarter, Holdings Channel reports. The institutional investor acquired 170,509 shares of the financial services provider’s stock, valued at approximately $28,419,000.
Several other institutional investors and hedge funds have also recently made changes to their positions in MRSH. Headlands Technologies LLC purchased a new position in shares of Marsh & McLennan Companies in the second quarter worth $29,000. Solstein Capital LLC bought a new stake in Marsh & McLennan Companies in the 4th quarter worth $25,000. SHP Wealth Management purchased a new position in shares of Marsh & McLennan Companies in the fourth quarter valued at about $26,000. KERR FINANCIAL PLANNING Corp bought a new position in shares of Marsh & McLennan Companies during the fourth quarter valued at about $27,000. Finally, Asset Dedication LLC purchased a new stake in shares of Marsh & McLennan Companies during the first quarter worth about $25,000. Institutional investors own 87.99% of the company’s stock.
Insider Transactions at Marsh & McLennan Companies
In other news, Director Lloyd Yates sold 12,000 shares of the company’s stock in a transaction dated Thursday, July 23rd. The shares were sold at an average price of $175.65, for a total value of $2,107,800.00. Following the sale, the director directly owned 12,001 shares of the company’s stock, valued at $2,107,975.65. This represents a 50.00% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Martin South sold 7,100 shares of Marsh & McLennan Companies stock in a transaction dated Tuesday, July 28th. The shares were sold at an average price of $189.99, for a total transaction of $1,348,929.00. Following the transaction, the insider directly owned 16,632 shares of the company’s stock, valued at approximately $3,159,913.68. This trade represents a 29.92% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 19,813 shares of company stock valued at $3,597,903 in the last three months. 0.38% of the stock is currently owned by company insiders.
Marsh & McLennan Companies Stock Performance
Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) last released its earnings results on Tuesday, July 21st. The financial services provider reported $2.96 EPS for the quarter, beating analysts’ consensus estimates of $2.89 by $0.07. The company had revenue of $7.28 billion during the quarter. Marsh & McLennan Companies had a return on equity of 32.67% and a net margin of 14.24%.The business’s revenue was up 6.2% on a year-over-year basis. Sell-side analysts forecast that Marsh & McLennan Companies, Inc. will post 10.44 earnings per share for the current year.
Marsh & McLennan Companies Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, August 14th. Stockholders of record on Thursday, July 23rd were issued a dividend of $0.99 per share. This is a boost from Marsh & McLennan Companies’s previous quarterly dividend of $0.90. The ex-dividend date was Thursday, July 23rd. This represents a $3.96 dividend on an annualized basis and a dividend yield of 2.1%. Marsh & McLennan Companies’s dividend payout ratio (DPR) is presently 48.41%.
Analyst Upgrades and Downgrades
A number of research analysts recently issued reports on MRSH shares. Wells Fargo & Company boosted their price target on Marsh & McLennan Companies from $186.00 to $188.00 and gave the company an “equal weight” rating in a report on Wednesday, July 22nd. JPMorgan Chase & Co. boosted their target price on Marsh & McLennan Companies from $206.00 to $212.00 and gave the company an “overweight” rating in a research note on Monday, July 13th. Weiss Ratings raised Marsh & McLennan Companies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, August 7th. Morgan Stanley lifted their price target on shares of Marsh & McLennan Companies from $180.00 to $200.00 and gave the company an “equal weight” rating in a report on Wednesday, August 19th. Finally, UBS Group upped their price objective on shares of Marsh & McLennan Companies from $212.00 to $216.00 and gave the stock a “buy” rating in a report on Monday, July 27th. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, eleven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $203.50.
Get Our Latest Research Report on MRSH
Marsh & McLennan Companies Company Profile
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Read More
- Five stocks we like better than Marsh & McLennan Companies
- The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story
- NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now
- Dropping the Dough: Yum! Brands Strategically Trims the Fat
- These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
